期刊文献+

一类创新药苯胺洛芬注射液镇痛作用研究 被引量:3

The Study of Abirritation of A First Type of New Drug, Felbinac Trometamol Injection
下载PDF
导出
摘要 目的:评价化学药品一类新药苯胺洛芬注射液的镇痛作用。方法:通过甲醛、热水、热板、电刺激致小鼠疼痛模型来评价苯胺洛芬注射液的镇痛作用,并选用了氟比洛芬酯注射液和喷他佐辛注射液进行对比研究。结果:苯胺洛芬注射液对甲醛、热板致小鼠疼痛模型均有明显的镇痛作用,且镇痛效果优于等剂量下的氟比洛芬酯注射液,但苯胺洛芬注射液对电刺激、热水致痛模型镇痛作用不明显。结论:苯胺洛芬注射液具有良好的镇痛作用,属于外周性镇痛药,其镇痛作用强于氟比洛芬酯注射液,是一个具有较大开发潜力的非甾体类镇痛新药。 Objective: To evaluate the abirritation of the First Type of New Drug, Felbinac Trometamol (FT) injection. Methods: a series of ache models were estimated to the abirritation of FT injection, such as Formaldehyde, hot water, electroforms stimulate and hot board methods. And the positive groups were Flurbiprofen Axetil and Pentazocine injection, respectively. Result: The abirritation of FT injection showed significantly which was superior to the same dosage of Flurbiprofen Axetil in Formaldehyde and hot board models, but not obviously in electro stimulate and hot water model. Conclusions: The abirritation of FT injection, a new peripheral abirritation of NSAIDs, is better than Flurbiprofen Axetil with a huge potential for development.
出处 《中国医药导刊》 2009年第8期1327-1329,1332,共4页 Chinese Journal of Medicinal Guide
基金 国家科技部科技型中小企业创新基金(基金号:2008第一批1254)
关键词 镇痛 苯胺洛芬 氟比洛芬酯 疼痛模型 外周性镇痛 Abirritation Felbinac Trometamo Flurbiprofen Axetil Ache model Peripheral abirritation
  • 相关文献

参考文献5

  • 1杜冠华,李学军等译.药理学实验指南--新药发现和药理学评价.北京.第一版.科学出版社.2001,507-508.
  • 2Murry CW, Porreca F, Cowan A. Mehtodological refinements to the mouse paw formalin test. Life Sci1988; 22:295-302.
  • 3Kithchen I, Crowder M. Assessment of the hot-plate anti-nociceptive test in mice. A new method for the for the statistical treatment of graded data. J Pharmacol Meth 1988; 13:1-7.
  • 4Luttinger D. Determination of antinociceptive activity of drugs in mice using different water pemperature in a tail-immersiontest. J Phannacol Meth,1985; 13:351-357.
  • 5Nilsen PL.Studies on algesimetry by electrical stimulation of the mouse tail. Acta Pharmacol Toxicol,1961; 18:10-22.

同被引文献14

  • 1施桂英.非甾体抗炎药的合理应用[J].临床药物治疗杂志,2006,4(4):12-16. 被引量:4
  • 2蒋利,郝晶安,黄佳盛.非甾体抗炎药的安全使用[J].临床肺科杂志,2007,12(1):89-89. 被引量:8
  • 3ICH Guidance for Industry ICH S7A:Safety Pharmacology Studies for Human Pharmaceuticals[ S]. 2001.
  • 4ICH Guidance for Industry ICI-I S7B:Safety Pharmacology Studies for assessing the potential for delayed ventricular repolarization ( QT interval prolongation) by Human Pharmaceuticals [ S ]. 2002.
  • 5化学药物一般药理学研究技术指导原则研究组.化学药物一般药理学研究技术指导原则[S].2005.
  • 6杜冠华,李学军,张永样,译.药理学实验指南[M].北京:科学出版社,2001.637.
  • 7Su H, Xie YL, Liu WB, et al. Methyl-monofluorination of ibu- profen selectively increases its inhibitory activity toward cyclooxy- genase-1 leading to enhanced analgesic activity and reduced gastric damage in vivo [J]. Bioorganic & Medicinal Chemistry Letters, 2011, 21 (15) : 3578-3582.
  • 8Clara De Palma, Rosanna Di Paola, Cristiana Perrotta. Ibu- profen-arginine generates nitric oxide and has enhanced anti- inflammatory effects [J]. Pharmacological Research, 2009, 60 (4) : 221-228.
  • 9Shields SD, Cavanaugh D J, Lee H, et al. Pain behaviorin the formalin test persists after ablation of the great majority of C-fiber nociceptors [J]. Pain, 2010, 151 (2) : 422-429.
  • 10张玉玲,佟继铭.疼痛实验动物模型研究概况[J].承德医学院学报,2009,26(2):195-198. 被引量:11

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部